A diagnostic system to predict the presence of 6-acetylmorphine (6AM) in opiate-positive urines was recently proposed. A twofold criterion based on the total morphine concentration and the total codeine to total morphine concentration ratio was identified. Using relative operating characteristic (ROC) analysis, it was determined that the diagnostic system had a sensitivity of 92%, a specificity of 79%, and an overall accuracy of 73%. We applied similar decision criteria to a study population of 125 opiatepositive urines collected from criminal justice clients of a West Coast reference laboratory. ROC analysis on this population produced very different results: a sensitivity of 91%, a specificity of 49%, and an accuracy of 45%. These data illustrate the importance of choosing a representative study population without any selection biases that may compromise the validity of the accuracy measure. The ROC plot is an important tool for assessing a clinical test's performance, but in order for toxicologists and Medical Review Officers to benefit from the diagnostic test results, they must also know the predictive value (based on test accuracy and the prevalence of heroin use) of the test results. They need to know how well the test predicts the presence of 6AM, and therefore, the illicit use of heroin, in the population of interest whether it be workplace, criminal justice, hospital emergency department clients, or a combination of all populations.
Introduction
The aim of forensic urine drug testing for opiates is the detection and deterrence of illicit heroin use. The detection of opiates routinely involves the analysis of total codeine and total morphine concentration in urine. Because of several factors such as codeine contamination of heroin, the metabolism of both codeine and diacetylmorphine to morphine, and the presence of codeine and morphine in poppy seeds, many unnecessary and expensive gas chromatographic-mass spectrometric (GC-MS) confirmation tests are performed. In over 300,000 specimens reviewed by Medical Review Officers (MROs), 87% of all the opiate-positive specimens were verified as negative (1). Although some authors have proposed guidelines for source differentiation based on the total codeine concentration, the total morphine concentration, or the total morphine to total codeine concentration ratio in urine (2,3) the only unequivocal sign of heroin use is the presence of 6-acetylmorphine (6AM). Unfortunately, because of the low concentration and the instability of 6AM, detection necessitates an additional assay separate from the total morphine and total codeine GC--MS assay. In order to avoid unnecessary testing on every presumptive opiate-positive specimen, the Department of Health and Human Services has proposed guidelines to identify which positive specimens are more likely to come from illicit heroin use. Their guidelines, which were scheduled to become effective May 1, 1998, require testing for 6AM in positive specimens with a total morphine concentration greater than 2000 ng/mL (1). Similarly, laboratories participating in the UDC proficiency tests of the College of American Pathologists (CAP) are instructed to test for 6AM in the specimens with a total morphine concentration of 5000 ng/mL or greater.
In a recent article, Fuller (4) proposed a statistical approach for evaluating guidelines such as those described to determine if the added time and expense of an additional GC-MS analysis for 6AM is warranted. The analysis he used is the relative operating characteristic (ROC) analysis, also referred to as receiver operating characteristic analysis. ROC analysis is a statistical method to evaluate a diagnostic system based on the signal detection theory. A diagnostic system is called upon to discriminate between two circumstances. The system looks for a particular "signal" defining it as a positive event and attempts to discriminate it from "noise" characterized as a negative event (5) . The accuracy of a diagnostic system depends on how well it discriminates between these two states or circumstances. There are two ways in which the event and diagnosis can agree, true positives (TP) and true negatives (TN). Conversely, there are two ways in which the event and diagnosis can disagree, false positives (FP) and false negatives (FN). All the results from a diagnostic system will fall into one of these four categories depending on the decision criteria of the system. If one considers the proportions rather than the frequencies of the diagnoses, then all the information from the system is contained in two proportions, the true-positive and the falsepositive proportions. The true-positive proportion, often referred to as sensitivity, describes the system's ability to diagnose the presence of a given state or circumstance. This proportion is determined by dividing the number of true positives (TP) by the sum of true positives and false negatives (FN), TP/(TP+FN). The false-positive proportion is 1 -specificity, where specificity is the ability of the system to diagnose the absence of a given state. The false-positive proportion is determined by dividing the number of false positives by the sum of the false positives and the true negatives, FP/(FP+TN). A test of diagnostic accuracy involves sensitivity and specificity; therefore, all the relevant data for calculating the accuracy are contained in these two proportions.
Converting raw frequencies to proportions illustrates a fundamental property of the ROC accuracy measure. Accuracy is independent of the relative frequencies or prevalence of the positive and negative events. Therefore, accuracy, based on the specificity and sensitivity of the diagnostic system, is inherent to the test and not the circumstances to which it is applied (6) .
In the diagnostic system proposed by Fuller (4), a positive diagnosis was a specimen containing 6AM along with morphine and codeine, implying illicit heroin use. A negative diagnosis was a specimen that contained morphine and/or codeine but did not contain 6AM, implying an opiate source other than illicit heroin. The purpose of Fuller's ROC analysis was to identify a decision criterion that was the best compromise between sensitivity and specificity. The decision criteria proposed by Fuller were the total morphine concentration (>5000 ng/mL) and the total codeine (TC) to total morphine (TM) concentration (TC/TM) ratio. He used the ROC analysis to determine the maximum TC/TM ratio that would be the best criterion for predicting the presence of 6AM in urine. Fuller stated the criteria that produced the statistically best compromise between sensitivity and specificity were a total morphine concentration >5000 ng/mL and a TC/TM ratio less than 0.125. At this decision threshold, the sensitivity of the diagnostic system is 92%, the specificity is 79%, and the accuracy is 73%. Fuller adds that these criteria may be useful to toxicologists and MROs in deciding if the additional analysis for 6AM is warranted or as a model for developing their own decision criteria given the type of heroin common in their area. Using Fuller's decision criteria as a model, we performed an ROC analysis on 125 opiate-positive urines collected from criminal justice clients of a West Coast reference laboratory to evaluate the role of the ROC plot in interpreting opiate GC-MS confirmation results.
Materials and Methods

Analysis
The extraction method and GC-MS analysis of 6AM were previously described by O'Neal and Poklis (7) . Briefly, 2H6-6AM was added to 5 mL of calibrators, controls, and specimens.
The urine was buffered to pH 6.0 with 2 mL of 0.1M phosphate buffer. The specimens were extracted with ZSDAU020 Clean Screen Extraction columns (United Chemical Technologies, Inc., Bristol, PA). The columns were conditioned with methanol (3 mL), deionized water (3 mL), and phosphate buffer (1 mL). The samples were then added to the columns and followed by deionized water (2 mL), 0.1M acetate buffer (2 mL), and methanol (3 mL). After drying, the analytes were eluted with 3 mL of methylene chloride/isopropanol (4:1) with 3% ammonium hydroxide. The eluent was dried under nitrogen at 40~ One-hundred microliters of pyridine/ propionic anhydride (1:1) was added, and the samples were heated for 1 h at 40~ After derivatization and drying, the samples were reconstituted with 50 ~L of toluene/hexane/ isoamyl alcohol (78:20:2). Two microliters of sample was injected onto the GC-MS.
Total codeine and total morphine concentrations were determined by liquid-liquid extraction after acid hydrolysis. Deuterated codeine and morphine were added to 2 mL of urine. The specimens were hydrolyzed with 1 mL of concentrated HC1 at 100~ for I h. After cooling, the samples were buffered to pH 9.0 with 12N NaOH and carbonate/bicarbonate (3:2) buffer. The specimens were extracted with 4.0 mL of chloroform/isopropanol (4:1). After the organic layer was dried, the samples were derivatized with propionic anhydride and pyridine (1:1) at 65~ for 30 min.
The specimens were analyzed on a Hewlett Packard (Palo Alto, CA) 5890 GC with a split/splitless injection port, a 7673 autosampler, and a 5791A mass selective detector (MSD). The column was an HP-1 capillary column (12 m x 0.2 mm, 0.33-]Jm film thickness). The oven temperature program was 170~ held for 1 rain, then ramped to 280~ at 10~
The MSD was operated in the SIM mode using the following ions: codeine, 355, 282, and 229; 2H3-codeine, 358 and 285; 6AM, 383, 324, and 268; 2HB-6AM, 333 and 389; morphine, 341,268, and 397; and 2H3-morphine, 344 and 271.
Specimen selection
Opiate-positive urine specimens were obtained from criminal justice clients and analyzed by the described method. The specimens were collected in two groups: 1.100 consecutive urines that had been confirmed positive by GC-MS for morphine >5000 ng/mL and 2.25 specimens with a total morphine concentration <5000 ng/mL. All specimens were kept frozen (-15~ to -10~ until the time of analysis.
ROC analysis
One-hundred twenty-five opiate-positive specimens were analyzed as described. The results were then subjected to ROC analysis similar to that described by Fuller (4) . A twofold decision criterion was evaluated for the ability to discriminate between opiate-positive specimens that contained 6AM and those that did not. The decision criteria consisted of a total morphine concentration greater than 5000 ng/mL and various total codeine to total morphine concentration ratios (TC/TM). A specimen with a total morphine concentration >5000 ng/mL and a TCfFM ratio less than the given criteria ratio was predicted to be positive for 6AM (Table I ). The percentage of specimens correctly identified as containing 6AM (true positives) were plotted on the y axis, and the resulting percentage of incorrectly identified specimens (false positives) were plotted on the x axis. As the TC/TM ratio was varied, the plotted points produced an ROC curve.
Results and Discussion
Fuller (4) generated an ROC plot with an inflection point at 21% false-positive rate and 92% true-positive rate by varying the TCfI'M ratio from <0.050 to <0.125, increasing in increments of 0.005. He stated that the overall accuracy of the decision criteria at that point is determined by the area under the curve. The inflection point of his curve had an x axis location of 21% so that 79% of the x axis was under the curve. The y axis location was 92%; therefore, 92% of the y axis was under the curve. The total area under the curve at that point was calculated as 79% x 92% = 73%. Using Fuller's decision criteria as a model, we performed an ROC analysis on 125 opiate-positive urines collected from criminal justice clients of a west coast reference laboratory. The quantitative results for these specimens are listed in Table II . The specimens were sorted according to increasing total morphine concentration. Using the 16 different criteria listed in Table I , we plotted the false-positive rate versus the truepositive rate producing the ROC plot shown in Figure 1 . Our data produced a plot that was quite different from Fuller's data. The false-positive proportion in our plot increased at a greater rate so that the specificity at the inflection point was 49% corresponding to a sensitivity of 91%. If we calculate accuracy as Fuller did, the accuracy of the diagnostic system at * The twofold criteria also included a total morphine concentration >5000 ng/mL. * There were no changes in the false positive and true positive rates between these intervals.
the inflection point would only be 49% x 91% = 45%. An accuracy of approximately 50% indicates there is no discrimination in the test system. According to Zweig and Campbell (6) and Swets (5) , the preferred measure of accuracy of a diagnostic system is not calculated from a single point on the curve but the entire area of the graph that lies beneath the curve. For each decision threshold, there is a combination of sensitivity and specificity, and only the entire spectrum of sensitivity/specificity pairs provides the complete evaluation of test accuracy (6) . Calculated in this manner, the accuracy of the diagnostic system using our data is 68%. With Fuller's data, the accuracy is 81%, slightly above his calculated value of 73%. Although the criteria applied to the two sample populations was similar, the calculated accuracies are very different. Our ROC analysis would lead one to conclude that there is no discriminatory value to this diagnostic system, i.e., it cannot discriminate between the opiate positive specimens which contain 6AM and therefore, come from illicit heroin use, and those that do not contain 6AM. The overall positive rates of the two sample populations differed by only 10%. Fuller had an overall positive rate of 72% (73 out of 102), and our rate was 62% (78 out of 125). However, there is a greater difference in the positive rates for the specimens that have a total morphine concentrations of >5000 ng/mL. In Fuller's set, 69 out of 77 (90%) were positive for 6AM, whereas only 73 out of 100 (73%) were positive in our sample set. The false-positive rate for Fuller's sample population does not increase above 21% because, of the specimens with total morphine >5000 ng/mL, only a few (8 of 77) were negative for 6AM. This difference in the false-positive rates of the sample populations is not related to the sensitivities of the analytical methods. The limit of detection for 6AM in our method is comparable to Fuller's method at 2 ng/mL. The stability of 6AM in urine is also not the cause of the difference in the false-positive rates because 6AM is stable in urine for at least 2 years if kept frozen (4) .
An important premise of ROC analysis is that if the data are converted to proportions rather than raw frequencies, the accuracy is independent of the prevalence of a positive event (heroin use). Upon examination of the results of the ROC analyses for Fuiler's and our sample populations, it appears that the prevalence of a positive result may affect the accuracy of the diagnostic system. As Swets (5) states, calculated values of accuracy are neither perfectly reliable, in the sense of being repeatable for the same system, nor perfectly valid, in the sense of measuring what they claim to be measuring. The problem lies not with the calculation of accuracy, but rather with the quality of the test population.
A better understanding of the ROC analysis and the importance of study design may help explain why it appears that prevalence, the actual occurrance within the test population, could affect the accuracy of this system. The first step in evaluating the accuracy of a laboratory test is to clearly define the clinical question by characterizing the subject population and stating the management decision to be made (8) . This aids in the proper selection of subjects to study so that they are representative of the target population. There are several populations to consider as the target population in urine drug testing: workplace, criminal justice, or hospital emergency department clients. Each of these populations has a very dissimilar incidence of heroin use. Because the ROC analysis and accuracy calculation are independent of the prevalence of the positive event, the test population does not have to reflect the actual prevalence. It is actually desirable to have an equal number of positive and negative specimens (6), but it is imperative to avoid any selection biases that could compromise the study's validity. Each sample included in the study should be randomly selected, and the results of the laboratory test should not influence the selection of test specimens.
Fuller (4) did not specify the source of the specimens or how they were selected (randomly or consecutively). He only stated that law enforcement urine specimens were included in the study to ensure that the selected specimens would include some donors that were heroin users. The selection of the study population in such a manner could bias the ROC analysis because a high percentage of heroin users were included. The measures of diagnostic accuracy used here, specificity, sensitivity, and ROC plots, are influenced by the spectrum of "disease" (in this case, heroin use) in both the target and sample population (6). Fuller's sample population has a high number of 6AM-positive specimens (90% of the >5000 ng/mL total morphine specimens), which could very easily influence the specificity of the ROC analysis. There was a low false-positive rate because only a few of the specimens with a total morphine concentration >5000 ng/mL were negative for 6AM. A 90% positive rate in samples with a total morphine concentration >5000 ng/mL does not accurately reflect the positive rate in the target population. Our specimens were collected from criminal justice clients who typically have a higher incidence of heroin use than the general population, but only 73% of the specimens >5000 ng/mL total morphine were positive for 6AM, resulting in a much lower specificity. In our study, there was no bias in the sample selection, and the sample population was closer to the desirable test population of equal numbers of positive and negative specimens. Although the .Z Table I .
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sample population selection in our study was not ideal, it does illustrate how selection of test subjects will affect sensitivity and specificity and, therefore, affect the calculated accuracy of the diagnostic system.
Fuller used ROC analysis to determine the best decision criteria for predicting the presence of 6AM in opiate positive urines. Using ROC plots alone to choose decision thresholds is an oversimplification of the role of ROC analysis in the process of patient management. Once the ROC analysis has been performed, and the diagnostic test proves to discriminate well, then the role of the test in the process of patient management is explored (6) . The ROC plot is the initial assessment in a complex process of decision making. There are several elements besides test performance that need to be considered when choosing the decision criteria, including the prevalence of heroin use and the relative cost of errors (false positives or negatives). In choosing decision criteria that yield the optimum sensitivity/specificity combination, prevalence must be considered because it interacts with specificity and sensitivity in determining the actual probabilities of false-positive and false-negative results in the target population.
The accuracy of a diagnostic test should be distinguished from the usefulness or predictive value of the information gained from the test. Whereas specificity and sensitivity are a measure of test performance, predictive value incorporates those measures with prevalence to address the meaning of the test result at the chosen decision threshold (6) . The predictive value of a positive result describes the fraction of all positive results that are correct, and the predictive value of a negative result is the fraction of all negative results that are correct. In order to determine if the added time and expense of an additional GC-MS confirmation test for 6AM is warranted, toxicologists and MROs may need more information than how well the diagnostic system performs. The predictive value of this diagnostic test is a property of the application of the test and, therefore, would be a better aid to toxicologists and MROs in interpreting confirmation results.
Conclusion
The ROC plot is an important tool for assessing a clinical test's performance. The model presented by Fuller could be valuable in measuring the accuracy of a system for diagnosing the presence or absence of 6AM in opiate positive urines, but it is imperative to select a representative study population. We performed an ROC analysis on a study population consisting of consecutively selected specimens from criminal justice clients. The calculated accuracy of this diagnostic test was only 68% because of the high percent of false positives. A diagnostic test with only 68% accuracy has limited utility in patient management.
If a diagnostic test is identified that can correctly discriminate between those specimens with and without 6AM (specimens from illicit heroin use versus other sources of morphine and codeine), then further steps can be taken to evaluate the role of this test in patient management. In order for toxicologists and MROs to benefit from diagnostic test results, they must also know the predictive value of the test results. They need to know how well the test predicts the presence of 6AM and, therefore, the illicit use of heroin, in the population of interest, whether it be workplace, criminal justice, hospital emergency department clients, or a combination of all populations. Using ROC plots alone to choose decision thresholds as to the presence or absence of 6AM in opiate positive urines is an oversimplification of the role of ROC analysis in urine drug testing.
